Grade My Investments
Home › Free Stock Grades › SRRK

Scholar Rock Holding Corporation (SRRK) Stock Grade

SRRK · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$5.9B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None

About Scholar Rock Holding Corporation's fundamentals

Scholar Rock Holding Corporation is a biotechnology company with a market capitalization of $7.1 billion that is currently unprofitable, having reported a net loss in its latest annual statement with a net margin of 0.0%. The company showed no year-over-year revenue growth, indicating flat sales performance in its most recent period. As a development-stage biotech firm, Scholar Rock does not pay a dividend and cannot be evaluated using standard profitability metrics like P/E ratio or return on equity.

Track SRRK free — no credit card required. Live grade + monthly AI report →